Voloridge Investment Management
ARRY

Voloridge Investment Management’s Array Biopharma Inc ARRY Stock Holding History

Voloridge Investment Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-109,961
Closed -$5.09M – 1296
2019
Q2 		$5.09M Buy
+109,961
New +$3.09M 0.14% 156
2018
Q2 		– Sell
-323,268
Closed -$5.28M – 675
2018
Q1 		$5.28M Buy
+323,268
New +$5.18M 0.12% 151
2017
Q3 		– Sell
-285,077
Closed -$2.39M – 587
2017
Q2 		$2.39M Sell
285,077
-519,824
-65% -$4.25M 0.06% 257
2017
Q1 		$7.2M Buy
804,901
+135,145
+20% +$1.44M 0.18% 149
2016
Q4 		$5.89M Sell
669,756
-390,427
-37% -$2.87M 0.13% 206
2016
Q3 		$7.16M Buy
+1,060,183
New +$4.1M 0.16% 89

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Voloridge Investment Management's ARRY Position: Q3 2019 in Review

Voloridge Investment Management sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 109,961 shares — an estimated $5.09M sold.

Voloridge Investment Management first reported a position in ARRY in Q3 2016 and held it in 6 quarters. The position peaked at $7.2M in Q1 2017. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Voloridge Investment Management reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Voloridge Investment Management sold 109,961 Array Biopharma Inc shares in Q3 2019, an estimated $5.09M.
  • Voloridge Investment Management first reported a position in Array Biopharma Inc in Q3 2016 and held it in 6 quarters.
  • Voloridge Investment Management's Array Biopharma Inc position peaked at $7.2M in Q1 2017.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Voloridge Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.